GLI2 and neoplasm: GLI2 knockdown using lentiviral-mediated shRNA downregulates genes related to HH and Wnt signalling pathways, including leucine-rich repeat-containing GPCR 5, inhibits tumour cell proliferation and invasive capacity, and induces apoptosis [35].